Citations

Mayo Clinic

Showing 10 of 108551 citations.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)
Boora, Ganesh K., Kanwar, Rahul , Kulkarni, Amit , Abyzov, Alexej , Sloan, Jeff A. , Ruddy, Kathryn J. , Banck, Michaela S., Loprinzi, Charles L. , Beutler, Andreas S. , Kulkarni, Amit A, Sloan, Jeff, Abyzov, Alexej

Cancer Medicine | January 14, 2016 | Volume: 5 | Issue: 4 | Pages: 631-639

10.1002/cam4.625 | PMID 26763541 Get It

AbstractPaclitaxel‐induced peripheral neuropathy (PIPN) cannot be predicted from clinical parameters and might have a pharmacogenomic basis. Previous studies identified single nucleotide variants (SNV) associated with PIPN. However, only a subset of findings has been confirmed to date in more than one study, suggesting a need for further re‐testing and validation in additional clinical cohorts. Candidate PIPN‐associated SNVs were identified from the literature. SNVs were retested in 119 patients selected by extreme phenotyping from 269 in NCCTG N08C1 (Alliance) as previously reported. SNV genotyping was performed by a combination of short‐read sequencing analysis and Taqman PCR. These 22 candidate PIPN SNVs were genotyped. Two of these, rs7349683 in the EPHA5 and rs3213619 in ABCB1 were found to be significantly associated with PIPN with an Odds ratios OR = 2.07 (P = 0.02) and OR = 0.12 (P = 0.03), respectively. In addition, three SNVs showed a trend toward a risk‐ or protective effect that was consistent with previous reports. The rs10509681 and rs11572080 in the gene CYP2C8*3 showed risk effect with an OR = 1.49 and rs1056836 in CYP1B1 showed a protective effect with an OR = 0.66. None of the other results supported the previously reported associations, including some SNVs displaying an opposite direction of effect from previous reports, including rs1058930 in CYP2C8, rs17222723 and rs8187710 in ABCC2, rs10771973 in FGD4, rs16916932 in CACNB2 and rs16948748 in PITPNA. Alliance N08C1 validated or supported a minority of previously reported SNV‐PIPN associations. Associations previously reported by multiple studies appeared to have a higher likelihood to be validated by Alliance N08C1.
Effect of Left Atrial Ablation Process and Strategy on Microemboli Formation During Irrigated Radiofrequency Catheter Ablation in an In Vivo Model
Takami, Mitsuru , Parker, Kay D., Welker, Kirk M. , Johnson, Susan B., Packer, Douglas L. , Lehmann, H. Immo

Circulation: Arrhythmia and Electrophysiology | January 14, 2016 | Volume: 9 | Issue: 1 | Pages: No page available

10.1161/circep.115.003226 | PMID 26763224 Get It

Background— Formation of microemboli during catheter ablation has been suggested as a cause for asymptomatic cerebral emboli. However, it is unknown which part of the process and ablation setting/strategy is most strongly related to this occurrence. Methods and Results— A total of 27 pigs were used. Catheter/sheath manipulations in left atrium were performed in 25 of 27 pigs outfitted with microemboli monitoring systems. Ablations using open-irrigated radiofrequency catheters were performed in 18 of 25 pigs. Two of 27 pigs did not undergo left atrial procedures and were injected with microembolic materials in the carotid artery to serve as positive controls. In total, 334 sheath/catheter manipulations (transseptal puncture, sheath flushing, catheter insertion, pulmonary vein venography, and sheath exchange) and 333 radiofrequency applications (power setting, 30/50 W; point-by-point/drag ablations) were analyzed. High microbubble volume in the extracorporeal circulation loop and a high number of microembolic signals in carotid artery were observed during sheath/catheter manipulations especially in saline/contrast injections at fast speed and ablations with steam pop. Fast sheath flushing produced significantly higher microbubble volume than slow sheath flushing (median, 12 200 versus 121 nL; P <0.0001). A total of 44 of 126 (35%) blood filters in the circulation loop showed microparticles (thrombus/coagulum and tissue). Most of them were seen after radiofrequency application especially in 50-W ablations, drag ablations, and steam pop. Brain magnetic resonance imaging showed positive-embolic lesions in control pigs. Conclusions— Formation of microbubbles was the greatest during fast saline/contrast injections and steam pops, whereas high-power radiofrequency applications, drag ablations, and steam pops produced most of the microparticles.
Penile and Scrotal Swelling: An Underrecognized Presentation of Crohn's Disease
Barrick, Benjamin J., Tollefson, Megha M. , Schoch, Jennifer J. , McEvoy, Marian T., Hand, Jennifer L. , Wieland, Carilyn N. , Davis, Dawn M. R., Davis, Dawn Marie R.

Pediatric Dermatology | January 14, 2016 | Volume: 33 | Issue: 2 | Pages: 172-177

10.1111/pde.12772 | PMID 26764123 Get It

AbstractBackground: Penile and scrotal swelling can occur as an extraintestinal manifestation of Crohn's disease (CD) and is thought to be an uncommon form of metastatic CD (MCD). Because of the rarity of this manifestation, much is unknown concerning the presentation, treatment, and response to therapy in children with genital MCD. Methods: Boys ages 1 to 17 years presenting with genital edema and a confirmed diagnosis or strong suspicion of CD who were evaluated at the Mayo Clinic between 1996 and 2014 were included for review. We sought to characterize the clinical and pathologic features of genital MCD and response to treatment in our cohort of patients. Results: Eight patients with genital MCD were identified from our institution (mean age 11.4 yrs, range 7–16yrs). Seven (88%) patients experienced cutaneous symptoms before a formal diagnosis of CD was made, and two of the seven had no adverse gastrointestinal symptoms at that time. Patients were prescribed an average of 3.4 medications (topical and systemic) for management of their gastrointestinal CD and MCD. Conclusions: Penile and scrotal swelling can occur as an extraintestinal manifestation of CD and is thought to be an uncommon form of MCD. In boys, genital swelling typically precedes intestinal CD. Treatment of the underlying CD with systemic medications was most helpful in this series. An evaluation for CD is necessary in all patients presenting with unexplained genital swelling.
Fifteen-Minute Detection of Streptococcus pyogenes in Throat Swabs by Use of a Commercially Available Point-of-Care PCR Assay
Uhl, James R., Patel, Robin , Patel, Robin

Journal of Clinical Microbiology | January 14, 2016 | Volume: 54 | Issue: 3 | Pages: 815-815

10.1128/jcm.03387-15 | PMID 26763964 Get It

Relationship between androgen deprivation therapy and community‐acquired respiratory infections in patients with prostate cancer
Schmid, Marianne , Hanske, Julian , Ravi, Praful , Krishna, Nandita , Reznor, Gally, Meyer, Christian P. , Fisch, Margit, Noldus, Joachim , Nguyen, Paul L. , Trinh, Quoc‐Dien

International Journal of Urology | January 14, 2016 | Volume: 23 | Issue: 4 | Pages: 305-311

10.1111/iju.13043 | PMID 26763083 Get It

ObjectivesTo investigate the dose‐dependent effect of androgen deprivation therapy on community‐acquired respiratory infections in patients with localized prostate cancer.MethodsWe identified 52 905 men diagnosed with localized prostate cancer within the Surveillance, Epidemiology and End Results‐Medicare database between 1991 and 2006. We compared those who did not receive androgen deprivation therapy with those who received androgen deprivation therapy within 2 years of diagnosis, calculated as monthly equivalent doses (<7, 7–11, >11 doses), or orchiectomy. Adjusted Cox hazard models were fitted to predict the risk of community‐acquired respiratory infections (acute sinusitis, acute bronchitis, [severe] pneumonia) in patients treated with medical androgen deprivation therapy versus orchiectomy versus none.ResultsOverall, 43.4% received medical androgen deprivation therapy. These patients more likely experienced respiratory events compared with those who did not receive androgen deprivation therapy or who underwent orchiectomy (62.2% vs 54.5% vs 47.8%, P < 0.001). The risk of experiencing any respiratory event increased with the number of doses received. For example, men receiving >11 doses of androgen deprivation therapy were at greatest risk of acute sinusitis, acute bronchitis and pneumonia (HR 1.13, 1.26 and 1.15, respectively, all P < 0.001), except severe pneumonia. Furthermore, we did not detect any relationship between orchiectomy and respiratory events. Study limitations include the utilization of a retrospective population‐based dataset.ConclusionsIncreased exposure to medical androgen deprivation therapy for men with localized prostate cancer is associated with a higher risk of community‐acquired respiratory infections. Our results suggest that respiratory complications represent potentially underreported complications of medical androgen deprivation therapy.
Authentic learning in anatomy: A primer on pragmatism
Pawlina, Wojciech, Drake, Richard L.

Anatomical Sciences Education | January 14, 2016 | Volume: 9 | Issue: 1 | Pages: 5-7

10.1002/ase.1592 | PMID 26763860 Get It

Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death
Thompson, Agnieszka K., Kelley, Benjamin , Murad, M. Hassan , Baum, Christian L. , Kelley, Benjamin F, Prokop, Larry J. , Murad, M Hassan

JAMA Dermatology | January 14, 2016 | Volume: 152 | Issue: 4 | Pages: 419

10.1001/jamadermatol.2015.4994 | PMID 26762219 Get It

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
Murtagh, Gillian , Laffin, Luke J. , Beshai, John F., Maffessanti, Francesco , Bonham, Catherine A. , Yu, Zoe, Addetia, Karima , Mor‐Avi, Victor , Sweiss, Nadera , Lang, Roberto M. , Patel, Amit R. , Patel, Amit V, Mor-Avi, Victor, Moss, Joshua D, Hogarth, D. Kyle , Sweiss, Nadera J, Patel, Amit , Moss, Joshua D.

Circulation: Cardiovascular Imaging | January 14, 2016 | Volume: 9 | Issue: 1 | Pages: No page available

10.1161/circimaging.115.003738 | PMID 26763280 Get It

Background— Cardiac sarcoidosis is associated with an increased risk of heart failure and sudden death, but its risk in patients with preserved left ventricular ejection fraction is unknown. Using cardiovascular magnetic resonance in patients with extracardiac sarcoidosis and preserved left ventricular ejection fraction, we sought to (1) determine the prevalence of cardiac sarcoidosis or associated myocardial damage, defined by the presence of late gadolinium enhancement (LGE), (2) quantify their risk of death/ventricular tachycardia (VT), and (3) identify imaging-based covariates that predict who is at greatest risk of death/VT. Methods and Results— Parameters of left and right ventricular function and LGE burden were measured in 205 patients with left ventricular ejection fraction >50% and extracardiac sarcoidosis who underwent cardiovascular magnetic resonance for LGE evaluation. The association between covariates and death/VT in the entire group and within the LGE+ group was determined using Cox proportional hazard models and time-dependent receiver–operator curves analysis. Forty-one of 205 patients (20%) had LGE; 12 of 205 (6%) died or had VT during follow-up; of these, 10 (83%) were in the LGE+ group. In the LGE+ group (1) the rate of death/VT per year was >20× higher than LGE− (4.9 versus 0.2%, P <0.01); (2) death/VT were associated with a greater burden of LGE (14±11 versus 5±5%, P <0.01) and right ventricular dysfunction (right ventricular EF 45±12 versus 53±28%, P =0.04). LGE burden was the best predictor of death/VT (area under the receiver-operating characteristics curve, 0.80); for every 1% increase of LGE burden, the hazard of death/VT increased by 8%. Conclusions— Sarcoidosis patients with LGE are at significant risk for death/VT, even with preserved left ventricular ejection fraction. Increased LGE burden and right ventricular dysfunction can identify LGE+ patients at highest risk of death/VT.
Validation of a bone scan positivity risk table in non‐metastatic castration‐resistant prostate cancer
Freedland, Stephen J. , Howard, Lauren E. , Hanyok, Brian T. , Kadiyala, Vishnu , Kuang, Jameson, Whitney, Colette , Wilks, Floyd , Amling, Christopher L. , Moreira, Daniel M. , Kane, Christopher J. , Terris, Martha K. , Cooperberg, Matthew R , Aronson, William J. , Howard, Lauren E

BJU International | January 13, 2016 | Volume: 118 | Issue: 4 | Pages: 570-577

10.1111/bju.13405 | PMID 26762961 Get It

Objectives To test the external validity of a previously developed risk table, designed to predict the probability of a positive bone scan among men with non‐metastatic (M0) castration‐resistant prostate cancer ( CRPC ), in a separate cohort. Patients and Methods We retrospectively analysed 429 bone scans of 281 patients with CRPC , with no known previous metastases, treated at three Veterans Affairs Medical Centers. We assessed the predictors of a positive scan using generalized estimating equations. Area under the curve ( AUC ), calibration plots and decision‐curve analysis were used to assess the performance of our previous model to predict a positive scan in the current data. Results A total of 113 scans (26%) were positive. On multivariable analysis, the only significant predictors of a positive scan were log‐transformed prostate‐specific antigen ( PSA ): hazard ratio ( HR ) 2.13; 95% confidence interval ( CI ) 1.71–2.66 ( P < 0.001) and log‐transformed PSA doubling time ( PSADT ): HR 0.53; 95% CI 0.41–0.68 ( P < 0.001). Among men with a PSA level <5 ng/ mL , the rate of positive scans was 5%. The previously developed risk table had an AUC of 0.735 to predict positive bone scan with excellent calibration, and provided additional net benefit in the decision‐curve analysis. Conclusion We have validated our previously developed table to predict the risk of a positive bone scan among men with M0/Mx CRPC . Use of this risk table may allow better tailoring of patients' scanning to identify metastases early, while minimizing over‐imaging. Regardless of PSADT , positive bone scans were rare in men with a PSA <5 ng/ mL .
Clinicians Report Difficulty Limiting Low-Value Services in Daily Practice
Grover, Michael , McLemore, Ryan, Tilburt, Jon C.

Journal of Primary Care & Community Health | January 13, 2016 | Volume: 7 | Issue: 2 | Pages: 135-138

10.1177/2150131915624112 | PMID 26763305 Get It

Health care services that increase costs but fail to improve health are of low value. Limiting low-value services has potential to decrease health care expenditures by eliminating waste. We examined the opinions of Continuing Medical Education attendees about the “Choosing Wisely” campaign and decreasing use of potentially unnecessary services of low value. We compared our attendees’ responses to those of participants who completed a survey a year earlier. Respondents acknowledged waste of resources as a common and serious problem and noted frequent opportunities to address low-value services with their patients. They also reported limited ability to successfully reduce unnecessary services in daily clinical care. Lack of familiarity with “Choosing Wisely” may be related.